Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Other Operating Expenses (2019 - 2020)

Historic Other Operating Expenses for Neurogene (NGNE) over the last 2 years, with Q1 2020 value amounting to $5.5 million.

  • Neurogene's Other Operating Expenses rose 518653.85% to $5.5 million in Q1 2020 from the same period last year, while for Mar 2023 it was $5.5 million, marking a year-over-year change of. This contributed to the annual value of $52.1 million for FY2019, which is N/A changed from last year.
  • Per Neurogene's latest filing, its Other Operating Expenses stood at $5.5 million for Q1 2020, which was up 518653.85% from $4.9 million recorded in Q4 2019.
  • Neurogene's 5-year Other Operating Expenses high stood at $49.1 million for Q3 2019, and its period low was $104000.0 during Q1 2019.